Roux-en-Y Gastric Bypass is Associated with Early Increased Risk Factors for Development of Calcium Oxalate Nephrolithiasis

Journal of the American College of Surgeons

Volumn 206, Issue 6, 2008, Pages 1145-1153

  Duffey, Branden G ^a   Pedro, Renato N ^a   Makhlouf, Antoine ^a   Kriedberg, Carly ^a   Stessman, Michelle ^a   Hinck, Bryan ^c   Ikramuddin, Sayeed ^b   Kellogg, Todd ^b   Slusarek, Bridget ^b   Monga, Manoj ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b University of Minnesota Physicians   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM OXALATE; CITRATE CALCIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; HYPEROXALURIA; MALE; MORBID OBESITY; NEPHROLITHIASIS; OBESITY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SURGICAL TECHNIQUE; UMBILICAL HERNIA; URINARY EXCRETION;

ADULT; CALCIUM OXALATE; COHORT STUDIES; FEMALE; GASTRIC BYPASS; HUMANS; HYPEROXALURIA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEPHROLITHIASIS; OBESITY; OXALATES; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 43849111071     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2008.01.015     Document Type: Article

References (53)

1. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
2. Must A., Spadano J., Coakley E.H., et al. The disease burden associated with overweight and obesity. JAMA 282 (1999) 1523-1529
3. Fontaine K.R., Redden D.T., Wang C., et al. Years of life lost due to obesity. JAMA 289 (2003) 187-193
4. NIH Conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 115 (1991) 956-961
5. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
6. Patriti A., Facchiano E., Sanna A., et al. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg 14 (2004) 840-848
7. Reinhold R.B. Late results of gastric bypass surgery for morbid obesity. J Am Coll Nutr 13 (1994) 326-331
8. Mehrotra C., Serdula M., Naimi T.S., et al. Population-based study of trends, costs, and complications of weight loss surgeries from 1990 to 2002. Obes Res 13 (2005) 2029-2034
9. Santry H.P., Gillen D.L., and Lauderdale D.S. Trends in bariatric surgical procedures. JAMA 294 (2005) 1909-1917
10. Shinogle J.A., Owings M.F., and Kozak L.J. Gastric bypass as treatment for obesity: trends, characteristics, and complications. Obes Res 13 (2005) 2202-2209
11. De Prisco C., and Levine S.N. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci 329 (2005) 57-61
12. Collazo-Clavell M.L., Jimenez A., Hodgson S.F., and Sarr M.G. Osteomalacia after Roux-en-Y gastric bypass. Endocr Pract 10 (2004) 195-198
13. Chaves L.C., Faintuch J., Kahwage S., and Alencar Fde A. A cluster of polyneuropathy and Wernicke-Korsakoff syndrome in a bariatric unit. Obes Surg 12 (2002) 328-334
14. Nelson W.K., Houghton S.G., Milliner D.S., et al. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis 1 (2005) 481-485
15. Daudon M., Lacour B., and Jungers P. Influence of body size on urinary stone composition in men and women. Urol Res 34 (2006) 193-199
16. Asplin J.R., and Coe F.L. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 177 (2007) 565-569
17. Sinha M.K., Collazo-Clavell M.L., Rule A., et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 71 (2007) 100
18. Kirkpatrick J.R. Jejunoileal bypass. A legacy of late complications. Arch Surg 122 (1987) 610-614
19. Hocking M.P., Davis G.L., Franzini D.A., and Woodward E.R. Long-term consequences after jejunoileal bypass for morbid obesity. Dig Dis Sci 43 (1998) 2493-2499
20. Scott Jr. H.W., Dean R.H., Shull H.J., and Gluck F. Results of jejunoileal bypass in two hundred patients with morbid obesity. Surg Gynecol Obstet 145 (1977) 661-673
21. Payne J.H., and DeWind L.T. Surgical treatment of obesity. Am J Surg 118 (1969) 141-147
22. DeWind L.T., and Payne J.H. Intestinal bypass surgery for morbid obesity. Long-term results. JAMA 236 (1976) 2298-2301
23. Organ Jr. C.H., Cegielski M.M., Grabner B.J., et al. Jejunoileal bypass. Long-term results. Ann Surg 192 (1980) 38-43
24. Hocking M.P., Duerson M.C., O'Leary J.P., and Woodward E.R. Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases. N Engl J Med 308 (1983) 995-999
25. Delaney A.G., Duerson M.C., and O'Leary J.P. The incidence of cholelithiasis after jejunoileal bypass. Int J Obes 4 (1980) 243-248
26. Mole D.R., Tomson C.R., Mortensen N., and Winearls C.G. Renal complications of jejuno-ileal bypass for obesity. QJM 94 (2001) 69-77
27. Clayman R.V., Buchwald H., Varco R.L., et al. Urolithiasis in patients with a jejunoileal bypass. Surg Gynecol Obstet 147 (1978) 225-230
28. Leff R.D., Towles W., Aldo-Benson M.A., et al. A prospective analysis of the arthritis syndrome and immune function in jejunoileal bypass patients. J Rheumatol 10 (1983) 612-618
29. Stauffer J.Q. Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption. Am J Dig Dis 22 (1977) 921-928
30. Dobbins J.W., and Binder H.J. Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 70 (1976) 1096-1100
31. Dobbins J.W., and Binder H.J. Importance of the colon in enteric hyperoxaluria. N Engl J Med 296 (1977) 298-301
32. Gregory J.G., Park K.Y., and Schoenberg H.W. Oxalate stone disease after intestinal resection. J Urol 117 (1977) 631-634
33. Durrani O., Morrisroe S., Jackman S., and Averch T. Analysis of stone disease in morbidly obese patients undergoing gastric bypass surgery. J Endourol 20 (2006) 749-752
34. Ledoux S., Msika S., Moussa F., et al. Comparison of nutritional consequences of conventional therapy of obesity, adjustable gastric banding, and gastric bypass. Obes Surg 16 (2006) 1041-1049
35. Robertson W.G., Peacock M., Heyburn P.J., et al. Risk factors in calcium stone disease of the urinary tract. Br J Urol 50 (1978) 449-454
36. Robertson W.G., and Peacock M. The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?. Nephron 26 (1980) 105-110
37. McLeod R.S., and Churchill D.N. Urolithiasis complicating inflammatory bowel disease. J Urol 148 (1992) 974-978
38. Nelson W.K., Fatima J., Houghton S.G., et al. The malabsorptive very, very long limb Roux-en-Y gastric bypass for super obesity: results in 257 patients. Surgery 140 (2006) 517-522 discussion 513-522
39. Allison M.J., Dawson K.A., Mayberry W.R., and Foss J.G. Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141 (1985) 1-7
40. Sidhu H., Schmidt M.E., Cornelius J.G., et al. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10 suppl 14 (1999) S334-S340
41. Siener R., Ebert D., and Hesse A. Urinary oxalate excretion in female calcium oxalate stone formers with and without a history of recurrent urinary tract infections. Urol Res 29 (2001) 245-248
42. Allison M.J., Cook H.M., Milne D.B., et al. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 116 (1986) 455-460
43. Hatch M., Cornelius J., Allison M., et al. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int 69 (2006) 691-698
44. Hoppe B., Leumann E., von Unruh G., et al. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci 8 (2003) e437-e443
45. Hylander E., Jarnum S., and Nielsen K. Calcium treatment of enteric hyperoxaluria after jejunoileal bypass for morbid obesity. Scand J Gastroenterol 15 (1980) 349-352
46. Nordenvall B., Backman L., Burman P., et al. Low-oxalate, low-fat dietary regimen in hyperoxaluria following jejunoileal bypass. Acta Chir Scand 149 (1983) 89-91
47. Hesse A., Siener R., Heynck H., and Jahnen A. The influence of dietary factors on the risk of urinary stone formation. Scanning Microsc 7 (1993) 1119-1127 discussion 1118-1127
48. Hesse A., and Siener R. Current aspects of epidemiology and nutrition in urinary stone disease. World J Urol 15 (1997) 165-171
49. Borghi L., Schianchi T., Meschi T., et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346 (2002) 77-84
50. Siener R., Ebert D., Nicolay C., and Hesse A. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Kidney Int 63 (2003) 1037-1043
51. Curhan G.C., Willett W.C., Rimm E.B., et al. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 143 (1996) 240-247
52. Grasso M., Loisides P., Beaghler M., and Bagley D. The case for primary endoscopic management of upper urinary tract calculi: I. A critical review of 121 extracorporeal shock-wave lithotripsy failures. Urology 45 (1995) 363-371
53. El-Nahas A.R., El-Assmy A.M., Mansour O., and Sheir K.Z. A prospective multivariate analysis of factors predicting stone disintegration by extracorporeal shock wave lithotripsy: the value of high-resolution noncontrast computed tomography. Eur Urol 51 (2007) 1688-1693 discussion 1684-1693